Efficacy and Safety of Bevacizumab/Temsirolimus Combination to Treat Advanced Renal Cell Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01264341
Recruitment Status : Terminated (Based on the developments in the treatment of recurrent metastatic renal cancer, the study treatment is no longer considered to be the best treatment option)
First Posted : December 21, 2010
Last Update Posted : February 14, 2017
Information provided by (Responsible Party):
Hellenic Cooperative Oncology Group

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : July 2015
  Actual Study Completion Date : July 2015